Associate Professor Anthony White PhD
“I am very excited for the potential of the Childhood Dementia Initiative to identify common therapeutic targets, providing a broader disease base for drug investment.”
Anthony White is Senior Group Leader, Cellular and Molecular Neurodegeneration, Mental Health and Neuroscience at the QIMR Berghofer Medical Research Institute.
Anthony obtained a PhD in neuroscience from Murdoch University in 1996, then undertook a post-doctoral position at the University of Melbourne investigating Alzheimer’s and prion diseases.
He worked at Imperial College of Medicine, UK, in 2001 studying immunotherapeutic approaches to prion diseases. He obtained an NHMRC RD Wright Fellowship (2004-2008) and established a research group at the Department of Pathology, University of Melbourne. Anthony investigated the role of biometals in neurodegeneration, including Batten Disease, and the development of metal-based drugs for the treatment of these disorders.
He received an ARC Future Fellowship in 2011, was recruited to QIMR Berghofer in 2016, and was awarded an NHMRC Senior Research Fellowship in 2017. His research has contributed to the development of first-in-class metal-drugs as a potential new therapeutic approach to treat motor neuron disease. He is currently developing new human patient-based models of neurodegeneration including microglia, 3D cultures, and organoids to improve translational outcomes for neurotherapeutics.
Read more about the members of our Scientific and Medical Advisory Committee.
